Cargando…
IL-25 induces type 2 cytokine production in a novel, steroid resistant IL-17RB(+) myeloid population that exacerbates asthmatic pathology
This study identifies the IL-25 receptor, IL-17RB, is an important mediator of both innate and adaptive pulmonary type 2 immune responses. Allergen exposure upregulated IL-25 and induced type 2 cytokine production in a novel granulocytic population, termed Type 2 Myeloid (T2M) cells. Il17rb(−/−) mic...
Autores principales: | Petersen, Bryan C., Budelsky, Alison L., Baptist, Alan P., Schaller, Matthew A., Lukacs, Nicholas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378776/ https://www.ncbi.nlm.nih.gov/pubmed/22543263 http://dx.doi.org/10.1038/nm.2735 |
Ejemplares similares
-
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014) -
Bronchial Vascular Remodeling Is Attenuated by Anti-IL-17 in Asthmatic Responses Exacerbated by LPS
por: Camargo, Leandro do Nascimento, et al.
Publicado: (2020) -
The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer
por: Bastid, Jérémy, et al.
Publicado: (2020) -
Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
por: Wu, Heng-Hsiung, et al.
Publicado: (2015) -
Contribution of IL-17 in Steroid Hyporesponsiveness in Obese Asthmatics Through Dysregulation of Glucocorticoid Receptors α and β
por: Al Heialy, Saba, et al.
Publicado: (2020)